Dynamic Changes in the Global Intragastric Balloon Market Outlook: Ken Research

0


The gastric balloon refers to a developed medical device that is efficiently utilized in an endoscopic intragastrical process, where the inflated silicone balloon is implanted in the stomach and is remembered there for 6-12 months.  It is extensively known as weight defeat balloon that is considered to support the individuals to eat less and feel full preferably while eating. This created less room for the food and effectively supports the body to adapt to healthy portions. This process is non-surgical, non-invasive, and demands no-incision. However, this process is not everlasting and assists individual to drop up to three times the weight when associated to diet alone. Apart from the weight loss it has several other health benefits as it supports in developing diabetes, manages cardiac health, and enhances other bone-related issues. Hence, with the effective advantages the global market of intragastric balloon will grow more positively in the coming years.

Intragastric Balloon Market

According to the report analysis, ‘Global Intragastric Balloon Market: Drivers, Opportunities, Trends and Forecast 2017-2023’ states that there are several key players which are presently functioning in this sector more actively for leading the fastest market growth and dominating the handsome value of market share across the globe throughout the short span of time while emerging the endo-bariatric technology for treating the obesity, effective rise in the prevalence for the chronic diseases and rising the popularity of outpatient process includes Apollo Endosurgery, Spatz FGIA, ReShape Medical, and Obalon Therapeutics, and other predominant & niche players. Moreover, the players of this market in the underdeveloped regions are decreasing the cost of intragastric balloons with the significant increase in the spending over the several research and development programs and developing the proper reimbursement policies which further benefitted for generating the high amount of revenue in the coming years.

The Global Intragastric Balloon Market is estimated to witness a CAGR of 9.6% during the forecast period 2017-2023. Whereas, the intragastric balloon suggests non-surgical and less invasive endoscopic process with the reversible weight measurement that has increased in the scale with tougher impression on the market. Therefore, as more EBT (Endoscopic Bariatric Therapies) are obtainable for the obese patients it will turn into more practicable and effective to assist long-term treatment in the near years. However, the EBT have shown greater results and less adverse events as the delivery of EBT needs the special room facility and preparation that will accommodate the size, weight, and surgical gowns for the patient.

Additionally, based on the region, the market of intragastric balloon is spread across the globe which effectively includes North America, Europe, Asia Pacific, and Rest of the World (RoW). However, the Americas is set to be the significant region for the intragastric balloon market growth followed by Europe. Asia Pacific region and RoW are set to be the emerging regions. The emerging markets have an extraordinary potential to increase due to an increase in the number of obese populace and its related chronic syndromes.

Although, the market in the developed regions are sighting an effective increase in the acceptance of gastric balloons, particularly in the US, Canada, France, Germany, and the UK and few of the Middle East Countries. These regions have the highest obese populace accounting to 70% to 75% of the total obese population globally. Therefore, in the near future, it is predicted that the market of intragastric balloon will increase more positively over the recent few years.

To know more, click on the link below:-

Global Intragastric Balloon Market

Contact Us:-

Ken Research

Ankur Gupta, Head Marketing & Communications

Sales@kenresearch.com

+91-9015378249

Share.